Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy.
Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy.
J. Hörner-Rieber,D. Bernhardt,10 著者,S. Rieken
2017 · DOI: 10.1016/j.radonc.2017.08.029
Radiotherapy and Oncology · 48 件の引用
TLDR
Prospective, multi-center studies are needed to evaluate the prognostic impact of histology and consecutively the need for SBRT dose adaptation.